Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795185

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795185

Troponin

PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Troponin Market to Reach US$1.5 Billion by 2030

The global market for Troponin estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Troponin I, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$671.3 Million by the end of the analysis period. Growth in the Troponin T segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.3 Million While China is Forecast to Grow at 7.6% CAGR

The Troponin market in the U.S. is estimated at US$315.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$301.4 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Troponin Market - Key Trends & Drivers Summarized

Why Is Troponin Central to Modern Cardiovascular Diagnostics?

Troponin, particularly its cardiac-specific forms (cTnI and cTnT), is a cornerstone of myocardial infarction diagnosis. When heart muscle damage occurs, troponin is released into the bloodstream, making it a precise and early indicator of cardiac events. Its use in emergency rooms for patients with chest pain has dramatically improved diagnostic speed and accuracy.

Beyond heart attacks, elevated troponin levels are being studied in heart failure, kidney disease, and even infections like COVID-19, where cardiac stress is present. Its expanding diagnostic scope is transforming troponin from a single-use marker into a multi-condition monitoring tool. This growing utility is fueling innovation in rapid testing and portable devices for real-time clinical decision-making.

How Are Technology and Clinical Protocols Influencing Troponin Testing Adoption?

High-sensitivity troponin assays are becoming the standard, enabling detection at ultra-low concentrations. This has enabled early rule-in/rule-out protocols that reduce unnecessary admissions and streamline emergency care. Diagnostic manufacturers are developing multiplex analyzers that combine troponin with other biomarkers for comprehensive cardiac profiling.

Clinical protocols now incorporate troponin testing into broader risk algorithms, supported by evidence-based guidelines. Portable testing devices with cloud connectivity and AI-driven interpretation are extending access to underserved and remote areas. Regulatory alignment and insurance reimbursement are also facilitating widespread adoption in hospitals and clinics worldwide.

The Growth in the Troponin Market Is Driven by Several Factors…

The growth in the troponin market is driven by several factors including increasing cardiovascular disease incidence, widespread deployment of high-sensitivity assays, and integration into risk-based clinical algorithms. The need for fast, accurate emergency diagnostics has driven investment in next-gen immunoassay platforms. The expansion of home-based and decentralized testing systems is opening up new distribution channels. Clinical guidelines are increasingly recommending routine troponin testing for high-risk populations, driving consistent demand in both acute and chronic care settings.

SCOPE OF STUDY:

The report analyzes the Troponin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Troponin I, Troponin T, Troponin Complex, Other Troponin Types); Application (Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Biomerieux SA
  • Boditech Med Inc.
  • Danaher Corporation (Beckman Coulter)
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujirebio Inc. (H.U. Group)
  • HyTest Ltd.
  • LumiraDx Limited
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38259

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Troponin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Events Propels Adoption of High-Sensitivity Troponin Assays
    • Integration of Troponin Testing in Emergency Protocols Strengthens Clinical Relevance Across Care Settings
    • Technological Advancements in Point-of-Care Diagnostics Expand Access to Troponin Testing
    • Shift Toward Multi-Marker Panels Throws the Spotlight on Troponin as a Central Biomarker
    • Increasing Investment in Decentralized Healthcare Drives Demand for Portable Testing Platforms
    • AI and Predictive Analytics Tools Enhance Interpretation and Stratification of Troponin Results
    • Widening Use of Troponin in Chronic Disease Monitoring Expands Diagnostic Applications
    • Regulatory Support for Early Detection Programs Sustains Market Momentum
    • Growing Hospital Accreditation Requirements Spur Standardization of Troponin Testing Protocols
    • Expansion of Telehealth and Remote Monitoring Enhances Relevance of Digital Troponin Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Troponin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Troponin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Troponin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Troponin I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Troponin I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Troponin I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Troponin T by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Troponin T by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Troponin T by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Troponin Complex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Troponin Complex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Troponin Complex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Troponin Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Troponin Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Troponin Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Myocardial Infarction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Acute Coronary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Acute Coronary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Acute Coronary Syndrome Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Congestive Heart Failure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Congestive Heart Failure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Congestive Heart Failure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiomyopathy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiomyopathy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiomyopathy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Troponin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Troponin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Troponin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Troponin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Troponin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Troponin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Troponin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Troponin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Troponin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Troponin by Type - Troponin I, Troponin T, Troponin Complex and Other Troponin Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Troponin by Type - Percentage Breakdown of Value Sales for Troponin I, Troponin T, Troponin Complex and Other Troponin Types for the Years 2014, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Troponin by Application - Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Troponin by Application - Percentage Breakdown of Value Sales for Myocardial Infarction Application, Acute Coronary Syndrome Application, Congestive Heart Failure Application, Cardiomyopathy Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!